OMICUnknown
Singular Genomics Systems, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Singular Genomics Systems, Inc. (OMIC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are OMIC insiders buying or selling?
Singular Genomics Systems, Inc. insiders reported 7 open-market buys ($35.3M) and 5 sells ($399.4K) across 12 Form 4 filings — a net buying position of $34.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 14, 2025)
Total Form 4 filings
12
SEC EDGAR
Insider filers
6
Insider buys (7)
$35.3M
Insider sells (5)
$399.4K
Insider sentiment
Net buyingNet insider flow of $34.9M in net buying.
Recent OMIC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 14, 2025 | Spaventa Andrew | Chief Executive Officer | Sale | 800 | $19.89 | $15.9K |
| Dec 17, 2024 | Spaventa Andrew | Chief Executive Officer | Sale | 180 | $20.16 | $3.6K |
| Nov 13, 2024 | Spaventa Andrew | Chief Executive Officer | Sale | 695 | $22.55 | $15.7K |
| Sep 18, 2024 | Kevin Tang | 10% Owner | Purchase | 122.4K | $14.75 | $1.8M |
| Sep 17, 2024 | Spaventa Andrew | Chief Executive Officer | Sale | 175 | $12.38 | $2.2K |
| Nov 20, 2023 | Spaventa Andrew | Chief Executive Officer | Purchase | 118.5K | $0.42 | $49.6K |
| Nov 20, 2023 | Glezer Eli N. | Chief Scientific Officer | Purchase | 200.0K | $0.43 | $85.6K |
| Aug 15, 2023 | Kim P. Kamdar | Director | Sale | 631.6K | $0.57 | $362.0K |
| May 19, 2023 | Glezer Eli N. | Chief Scientific Officer | Purchase | 170.0K | $0.82 | $138.9K |
| Dec 13, 2022 | Glezer Eli N. | Chief Scientific Officer | Purchase | 50.0K | $2.00 | $100.0K |
| May 19, 2022 | Michael J Pellini | Director | Purchase | 26.8K | $3.30 | $88.6K |
| Jun 3, 2021 | Flynn James E | Other, 10% Owner | Purchase | 1.5M | $22.00 | $33.0M |
Showing the 12 most recent of 12 Form 4 filings for Singular Genomics Systems, Inc..
Most active OMIC insiders
- Spaventa Andrew5 filings
- Glezer Eli N.3 filings
- Flynn James E1 filing
- Kevin Tang1 filing
- Kim P. Kamdar1 filing
Ask anything about OMIC insider activity
Use Trabud's AI agent to query Singular Genomics Systems, Inc.'s Form 4 history in plain English — "Show me OMIC CEO purchases this year" or compare it against any other ticker.
Open the AI agentOMIC insider trading FAQ
Are Singular Genomics Systems, Inc. insiders buying or selling?
Across 12 SEC Form 4 filings, Singular Genomics Systems, Inc. (OMIC) insiders reported 7 open-market purchases totaling $35.3M and 5 sales totaling $399.4K. That is a net buying position of $34.9M.
How many insiders trade OMIC stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Singular Genomics Systems, Inc.. The most recent filing was accepted on Feb 14, 2025.
Where does Trabud get OMIC insider trading data?
All OMIC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.